Couverture de The Growth Blueprint

The Growth Blueprint

The Growth Blueprint

De : Simon-Kucher
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Step into The Growth Blueprint, where Simon-Kucher’s partners reveal bold strategies defining the future of business. Each episode dives into powerful, actionable insights across financial services, healthcare and pharma, industrials, TMT, and consumer – spotlight the trends reshaping markets and the solutions driving real impact. Get inspired, get informed, and get ahead. Discover what it truly takes to achieve sustainable, transformative growth in 2026 and beyond. Tune in and elevate your strategy to the next level.Copyright 2024 Economie Management Management et direction
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • From hype to value: How AI is reshaping growth in technology and software
      Dec 15 2025

      In this episode of The Growth Blueprint, Sara Yamase, Global Head of TMT, and Eddie Hartman, Senior Partner and Board Member, unpack how AI is moving from hype to real business value. They explore how companies can use proprietary data and intelligent product design to differentiate in an increasingly commoditized AI landscape. The conversation dives into the evolution of pricing and monetization models, from usage-based and outcome-based pricing to smarter ways of capturing value. Discover how technology leaders can balance rapid innovation with human decision-making. For more resources, please visit: https://www.simon-kucher.com/.

      Afficher plus Afficher moins
      33 min
    • MFN, EU JCA & Equitable access: How 2026 will reshape global pharma and biotech
      Dec 15 2025

      In this episode of The Growth Blueprint, Senior Partners Christian Schuler and Robert Dumitrescu discuss how global pharma and biotech are being transformed by Most Favored Nation pricing, Europe’s new Joint Clinical Assessment framework, and the growing focus on equitable access. Together they explore how these trends affect global pricing, evidence generation, launch strategy, and BD&L. Discover practical steps companies can take to adapt portfolios, access strategies, and deal structures for 2026 and beyond. For more resources, please visit: https://www.simon-kucher.com/

      Afficher plus Afficher moins
      31 min
    • Finding growth in a low-growth world: Resilience and reinvention in industrials
      Dec 15 2025

      In this episode of The Growth Blueprint, Adam Echter, Global Head of Industrials, speaks to partners Daniel Bornemann, and Dave Clement to discuss how industrial companies are redefining growth in an era of volatility. They explore the macro trends shaping 2026, from private equity’s renewed focus on operational excellence to the rise of AI-driven commercial transformation and the realities of “post-hype” sustainability. The conversation highlights how industrial leaders can move from bold reactions to disciplined execution, turning uncertainty into opportunity. For more resources, please visit: https://www.simon-kucher.com/.

      Afficher plus Afficher moins
      20 min
    Aucun commentaire pour le moment